Related references
Note: Only part of the references are listed.Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer
Silke Gillessen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer
Tess V. Clendenen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Conjugated equine estrogens and colorectal cancer incidence and survival: The women's health initiative randomized clinical trial
Cheryl Ritenbaugh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women
Marc J. Gunter et al.
CANCER RESEARCH (2008)
Associations between ERα, ERβ, and AR genotypes and colon and rectal cancer
ML Slattery et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Androgens, insulin resistance and vascular disease in men
D Kapoor et al.
CLINICAL ENDOCRINOLOGY (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Estrogen plus progestin and colorectal cancer in postmenopausal women
RT Chlebowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
American society of clinical oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer
DA Loblaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor
DR Chesire et al.
ONCOGENE (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Oral contraceptives and colorectal cancer risk: a meta-analysis
E Fernandez et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
